Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 12/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.36 |
| ▸ | HINT1 | P49773 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20481728 | 0.95 | TYMP (0.49) | TYMPKDM4ETAS1R3TAS1R1HPGD | |
| SCHEMBL29049087 | 0.95 | TYMP (0.57) | TYMPKDM4ETAS1R3TAS1R1NT5E | |
| SCHEMBL18954959 | 0.95 | TYMP (0.57) | TYMPKDM4ETAS1R3TAS1R1NT5E | |
| SCHEMBL27154531 | 0.95 | TYMP (0.57) | TYMPKDM4ETAS1R3TAS1R1NT5E | |
| SCHEMBL17230951 | 0.95 | TYMP (0.57) | TYMPKDM4ETAS1R3TAS1R1NT5E | |
| SCHEMBL19493328 | 0.95 | TYMP (0.57) | TYMPKDM4ETAS1R3TAS1R1NT5E | |
| SCHEMBL18954960 | 0.95 | TYMP (0.57) | TYMPKDM4ETAS1R3TAS1R1NT5E | |
| SCHEMBL21591933 | 0.95 | TYMP (0.57) | TYMPKDM4ETAS1R3TAS1R1NT5E | |
| SCHEMBL1582220 | 0.95 | TYMP (0.57) | TYMPKDM4ETAS1R3TAS1R1NT5E | |
| SCHEMBL10276802 | 0.95 | TYMP (0.57) | TYMPKDM4ETAS1R3TAS1R1NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303613-A1 | 3′3′ CYCLIC DINUCLEOTIDES WITH AN ALKENYLENE | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR, V.V.I. (CZ) | 2023-09-28 | — | — | US | disclosed |
| EP-3936514-B1 | 3'3' CYCLIC DINUCLEOTIDES WITH AN ALKENYLENE | INST OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR V V I (CZ) | 2023-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303613-A1 | 3′3′ CYCLIC DINUCLEOTIDES WITH AN ALKENYLENE | STING1, CGAS, IRF3 | TYMP 68/4885KDM4E 3233/4885TAS1R3 1487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.